Jonathan A. Ledermann - Publications, H-index & Citations

Jonathan A. Ledermann

university college london

89H指数

502论文数

5.0W被引数

收录论文 139

发表时间

Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026

International Journal of Gynecological Cancer

IF4.7

2026-07-11

PREAI

Houssein El Hajj; Alexander Shushkevich; Joanna Kacperczyk-Bartnik; Andrej Cokan; Ilker Kahramanoglu; Tibor Andrea Zwimpfer; Richard Tóth; Aleksandra Strojna; David Viveros-Carreño; Nicolò Bizzarri; Martina Aida Angeles; Khayal Gasimli; Ilker Selcuk; Giuseppe Caruso; Jonathan Ledermann; Viola Heinzelmann-Schwarz

Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial SOLO2试验中，BRCA突变铂敏感复发性浆液性卵巢癌患者接受奥拉帕利维持治疗后的不良事件特征

International Journal of Gynecological Cancer

IF4.7

2026-03-02

OAAI

Jonathan A. Ledermann; Alain Lortholary; Richard T. Penson; Rebecca Asher; Val Gebski; Diane Provencher; Ilan Bruchim; Tomasz Huzarski; Maria Pilar Barretina-Ginesta; Stefania Pipitone; Linda Mileshkin; Nicoletta Colombo; Tjoung-Won Park-Simon; Koji Matsumoto; Ingrid Boere; Olga Mikheeva; Jae-Weon Kim; Gustavo Girotto; Ignace Vergote; Dave Carter

The PARP inhibitor/Immunotherapy Paradox in Advanced Ovarian Cancer: Positive Endpoints, Perplexing Interpretations 晚期卵巢癌的PARP抑制剂/免疫疗法悖论: 阳性终点，令人困惑的解释

Annals of Oncology

IF65.4

2025-12-11

PREAI

Jonathan A. Ledermann; Robert L. Coleman

INTERLACE: not a new standard for cervical cancer chemoradiation – Authors' reply INTERLACE：并非宫颈癌放化疗的新标准——作者回复

lancet

IF0

2025-08-21

PREAI

Mary McCormack; Gemma Eminowicz; Simran Vaja; Allan Hackshaw; Jonathan Ledermann

The ENYGO Multidisciplinary Tumor Board Mechanisms of drug resistance: PARP inhibitors, Antibody-drug-conjugates (ADCs), and Immunotherapy ENYGO多学科肿瘤委员会：耐药机制——PARP抑制剂、抗体药物偶联物（ADC）和免疫治疗

International Journal of Gynecological Cancer

IF4.7

2025-08-19

PREAI

Diana Bello Roufai; Richard Toth; Upasana Palo; Giula Scaglione; Ana Tatiana Palacios; Zoltan Novak; Houssein El Hajj; Alexander Shushkevich; Jonathan Ledermann

ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025 ESGO–ESTRO–ESP关于子宫内膜癌患者管理的指南：2025年更新

lancet oncology

IF0

2025-07-28

PREAI

Nicole Concin; Xavier Matias-Guiu; David Cibula; Nicoletta Colombo; Carien L Creutzberg; Jonathan Ledermann; Mansoor Raza Mirza; Ignace Vergote; Nadeem R Abu-Rustum; Tjalling Bosse; Cyrus Chargari; Sophie Espenel; Anna Fagotti; Christina Fotopoulou; Sonia Gatius; Antonio González-Martin; Sigurd Lax; Bar Levy; Domenica Lorusso; Gabriella Macchia; Christian Marth; Philippe Morice; Ana Oaknin; Maria Rosaria Raspollini; Richard Schwameis; Jalid Sehouli; Alina Sturdza; Alexandra Taylor; Anneke Westermann; Pauline Wimberger; François Planchamp; Remi A Nout

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial Rucaparib用于铂敏感、复发性卵巢癌的维持治疗：III期、随机、安慰剂对照ARIEL3试验的最终结果

European Journal of Cancer

IF7.1

2025-06-17

OAAI

Jonathan A. Ledermann; Amit M. Oza; Domenica Lorusso; Carol Aghajanian; Ana Oaknin; Andrew Dean; Nicoletta Colombo; Johanne I. Weberpals; Andrew R. Clamp; Giovanni Scambia; Alexandra Leary; Robert W. Holloway; Margarita Amenedo Gancedo; Peter C. Fong; Jeffrey C. Goh; David M. O’Malley; Deborah K. Armstrong; Susana Banerjee; Jesús García-Donas; Elizabeth M. Swisher; Robert L. Coleman

Controversies and clinical unknowns in the use of PARP inhibitors in ovarian cancer Mukherjee, U.A.; Miller, R.E.; Ledermann, J.A. 卵巢癌中PARP抑制剂使用中的争议与临床未知因素。Ther. Adv. Med. Oncol. 2025, 17, 17588359251343973. [Google Scholar] [CrossRef] [PubMed]

Therapeutic Advances in Medical Oncology

IF4.2

2025-06-14

OAAI

Uma A. Mukherjee; Rowan E. Miller; Jonathan A. Ledermann

Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial 在无胚系BRCA1和/或BRCA2突变且对铂类敏感的复发性卵巢癌患者中应用奥拉帕尼单药维持治疗：OPINION试验的最终总生存结果

gynecologic oncology

IF4.1

2025-06-01

OAAI

Poveda, Andres; Lheureux, Stephanie; Colombo, Nicoletta; Cibula, David; Elstrand, Mari; Weberpals, Johanne; Bjurberg, Maria; Oaknin, Ana; Sikorska, Magdalena; Gonzalez-Martin, Antonio; Madry, Radoslaw; Perez, Maria Jesus Rubio; Ledermann, Jonathan; Romero, Ignacio; Ozgoren, Ozan; Barnicle, Alan; Marshall, Helen; Bashir, Zahid; Kof, Erik

Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial 局部晚期宫颈癌的诱导化疗后行同步放化疗：GCIG INTERLACE试验的生活质量结果

EUROPEAN JOURNAL OF CANCER

IF7.1

2025-05-01

PREAI

Eminowicz, G.; Vaja, S.; Gallardo, D.; Kent, C.; Panades, M.; Mathew, T.; Anand, A.; Forrest, J.; Adusumalli, M.; Chan, A.; Hacker, A. M.; Hackshaw, A.; Ledermann, J. A.; McCormack, M.

A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population☆一项多中心回顾性研究，旨在评估在脆弱、老年上皮性卵巢癌患者中，一线卡铂-紫杉醇方案相较于卡铂单药治疗的可行性、安全性与有效性☆

International Journal of Gynecological Cancer

IF4.7

2025-04-19

PREAI

Eve Merry; Ronas Taner Kesmez; Tamara Yu; Michael Flynn; Jonathan Ledermann; Michelle Lockley; Nicola Macdonald; Mary McCormack; Shibani Nicum; Shanthini Crusz; Rowan Miller

ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety ENGOT-OV16/NOVA试验中 niraparib 治疗复发卵巢癌的生存率与长期安全性

gynecologic oncology

IF4.1

2025-04-01

PREAI

Matulonis, Ursula A.; Herrstedt, Jorn; Oza, Amit; Mahner, Sven; Redondo, Andres; Berton, Dominique; Berek, Jonathan S.; Haslund, Charlotte A.; Marme, Frederik; Gonzalez-Martin, Antonio; Becourt, Stephanie; Tinker, Anna, V; Ledermann, Jonathan A.; Benigno, Benedict; Lindahl, Gabriel; Colombo, Nicoletta; Malinowska, Izabela A.; Liu, Wenlei; Bains, Manjinder; Monk, Bradley J.; Mirza, Mansoor R.

Controversies in the management of rare gynecologic cancers 罕见妇科肿瘤管理的争议

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

IF4.7

2025-03-01

PREAI

Gershenson, David M.; Ledermann, Jonathan; Ray-Coquard, Isabelle

Incorporating immune checkpoint inhibitors in epithelial ovarian cancer 将免疫检查点抑制剂应用于上皮性卵巢癌

gynecologic oncology

IF4.1

2025-02-01

PREAI

Bogani, Giorgio; Moore, Kathleen N.; Ray-Coquard, Isabelle; Lorusso, Domenica; Matulonis, Ursula A.; Ledermann, Jonathan A.; Gonzalez-Martin, Antonio; Kurtz, Jean-Emmanuel; Pujade-Lauraine, Eric; Scambia, Giovanni; Caruso, Giuseppe; Raspagliesi, Francesco; Colombo, Nicoletta; Monk, Bradley J.

The Incidence Of Breast Cancer In Ovarian Cancer Patients With BRCA Mutations: A Multicentre Retrospective Cohort Study.BRCA突变卵巢癌患者中乳腺癌的发病率：一项多中心回顾性队列研究。

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

IF4.7

2025-02-01

PREAI

Yongue, Gabriella; Counsell, Nicholas; Morgan, Robert D.; Tookman, Laura; Devlin, Michael-John; Miller, Rowan; Modawi, Mumin; Leytes, Sophia; Hunt, Ashton; Clamp, Andrew R.; Evans, Gareth R.; Jayson, Gordon C.; Elyashiv, Osnat; Levy, Tally; Abu Remilah, Areen; Ledermann, Jonathan A.; Nicum., Shibani

Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib 在评估奥拉帕尼的六项临床试验中，超过2000名卵巢癌患者的基因组不稳定性模式

GENOME MEDICINE

IF11.2

2024-12-18

OAAI

Barnicle, Alan; Ray-Coquard, Isabelle; Rouleau, Etienne; Cadoo, Karen; Simpkins, Fiona; Aghajanian, Carol; Leary, Alexandra; Poveda, Andres; Lheureux, Stephanie; Pujade-Lauraine, Eric; You, Benoit; Ledermann, Jonathan; Matulonis, Ursula; Gourley, Charlie; Timms, Kirsten M.; Lai, Zhongwu; Hodgson, Darren R.; Elks, Cathy E.; Dearden, Simon; Egile, Coumaran; Lao-Sirieix, Pierre; Harrington, Elizabeth A.; Brown, Jessica S.

Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3trial 局部晚期宫颈癌患者的诱导化疗后标准放化疗与单独标准放化疗 (GCIG INTERLACE): 一项国际多中心随机3期试验

LANCET

IF88.5

2024-10-01

OAAI

McCormack, Mary; Eminowicz, Gemma; Gallardo, Dolores; Diez, Patricia; Farrelly, Laura; Kent, Christopher; Hudson, Emma; Panades, Miguel; Mathew, Tony; Anand, Anjana; Persic, Mojca; Forrest, Jennifer; Bhana, Rajanee; Reed, Nicholas; Drake, Anne; Adusumalli, Madhavi; Mukhopadhyay, Asima; King, Margaret; Whitmarsh, Karen; McGrane, John; Colombo, Nicoletta; Mak, Choi; Mandal, Ranajit; Chowdhury, Rahul Roy; Alamilla-Garcia, Gabriela; Chavez-Blanco, Adriana; Stobart, Hilary; Feeney, Amanda; Vaja, Simran; Hacker, Anne-Marie; Hackshaw, Allan; Ledermann, Jonathan Andrew

ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy ICON9: 国际III期随机研究，旨在评估奥拉帕利联合西地尼布或奥拉帕利单药维持治疗在铂类化疗有效后复发的铂敏感卵巢癌患者中的疗效。

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Nicum, S.; Ledermann, J. A.; Mileshkin, L.; Jayson, G. C.; Gourley, C.; Michael, A.; Lord, R.; Mackay, H.; Hall, M.; Tookman, L.; Banerjee, S.; Harnett, P.; Macdonald, I.; Lee, Y. C.; Elyashiv, O.; Wilkinson, K.; Farrelly, L.; Counsell, N.

Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial 局部晚期宫颈癌的诱导化疗后序贯同步放化疗：GCIG INTERLACE试验的生活质量结局

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Eminowicz, G.; Vaja, S.; Gallardo, D.; Kent, C.; Panades, M.; Anand, A.; Persic, M.; Forrest, J.; Bhana, R.; Adusumalli, M.; Chan, A.; Hacker, A. M.; Hackshaw, A.; Ledermann, J. A.; McCormack, M.

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease ESGO-ESMO-ESP共识会议关于卵巢癌的建议: 病理学和分子生物学以及早期，晚期和复发性疾病

ANNALS OF ONCOLOGY

IF65.4

2024-03-01

OAAI

Ledermann, J. A.; Matias-Guiu, X.; Amant, F.; Concin, N.; Davidson, B.; Fotopoulou, C.; Gonzalez-Martin, A.; Gourley, C.; Leary, A.; Lorusso, D.; Banerjee, S.; Chiva, L.; Cibula, D.; Colombo, N.; Croce, S.; Eriksson, A. G.; Falandry, C.; Fischerova, D.; Harter, P.; Joly, F.; Lazaro, C.; Lok, C.; Mahner, S.; Marme, F.; Marth, C.; McCluggage, W. G.; Mcneish, I. A.; Morice, P.; Nicum, S.; Oaknin, A.; Perez-Fidalgo, J. A.; Pignata, S.; Ramirez, P. T.; Ray-Coquard, I.; Romero, I.; Scambia, G.; Sehouli, J.; Shapira-Frommer, R.; Sundar, S.; Tan, D. S. P.; Taskiran, C.; van Driel, W. J.; Vergote, I.; Planchamp, F.; Sessa, C.; Fagotti, A.

研究方向